How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BN

XETRA:BRAIN
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BN

BRAIN Biotech AGXETRA BRAIN Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XETR - Xetra

FAIR VALUE

Is BNN undervalued compared to its fair value?

The fair value of BNN stock is hidden EUR. Relative to the market price of 2.17 EUR BRAIN Biotech AG is hidden.

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currentl...[More about valuation]

BRAIN Biotech AG Fair Value

Available for registered user
UNLOCK
What is fair value?

Market cap:

0.051 $B

Price:

2.17 EUR

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.088

FINANCIALS

BRAIN Biotech AG financial for reporting period

Income Statement

0.015 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0012 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0019 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0.015 B 100%
0.0086 B 59%
-0.0012 B -8%
-0.0019 B -13%

Balance Sheet

0.073 B
0.018 B


Financial Position Analysis

Assets

0.073 B
Current Assets
0.029 B
Total non-current assets
0.044 B

Total current liabilities
0.015 B
Total non-current liabilities
0.04 B

Cash Flow Statement

0.0074 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0005 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

BRAIN Biotech AG fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-38 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-9 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-11 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

BRAIN Rating

Is BNN attractive for investment based on fundamental analysis?

BNN stock rating is hidden. BRAIN Biotech AG is a hidden by Eyestock methodology.

Get BNN Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-14

Gross Margin:

57

CFO / Debt ratio:

hidden

Current ratio:

1.659

Debt / Equity ratio:

0.44

ROE:

-38

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BNN.DE analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BNN.DE to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

BRAIN Biotech AG dividends

BNN.DE dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BNN.DE stock

About the company BRAIN Biotech AG

Market cap $B

0.051

Dividend yield

Shares outstanding

21.8475 B

BRAIN Biotech AG is a technology company, which engages in the development and commercialization of bioactives, natural compounds, and proprietary enzymes. The company is headquartered in Zwingenberg, Hessen and currently employs 307 full-time employees. The company went IPO on 2016-02-09. Research & Development activities focus on bioactive natural compounds, tailored enzymes and high-performance microorganisms.

BNN.DE profile

  • Ticker

    BNN.DE

  • Country

    Germany

  • Exchange

    XETR - Xetra

  • Report currency

    EUR - Euro

  • IPO date

    09 February 2016

  • Sector

    Materials

  • Industry

    Chemicals

  • Employees

    307

  • City

    Zwingenberg

  • Address

    Darmstaedter Strasse 34-36

  • Cusip

    D1R155106

Frequently Asked Questions

What sector does BRAIN operate in?

BRAIN operates in Materials sector

What is market cap of BRAIN?

Market cap of BRAIN is 0.051 USD as of 24 Jul 2024

What is market price of one BNN stock?

Market price of one BNN stock is 2.17 EUR as of 24 Jul 2024

What is BRAIN revenue?

According to the recent report BRAIN revenue is 14.662

What is BRAIN net income?

According to the recent report BRAIN net icnome is -1.918

What is BRAIN net income growh rate?

Net income growth rate of BRAIN is 15